surmount-1 trial tirzepatide non-diabetic weight loss SURMOUNT-1: Drastically Reduces in Obese Patients Comparison of Clinical Efficacy and

Healthcare providers usually start patients on a low dose of semaglutide and increase the dose over time as your body gets used to the medication

If cost is on your mind, the consultation is the place to sort out payment plans and whether an HSA or FSA can be used, with no pressure to decide on the spot

Studies have reported an average weight loss of around 15% or more of total body weight in participants who received semaglutide

The drugs stimulate the body to release more insulin after meals, helping to reduce post-meal blood sugar spikes

Less common serious side effects include seizures, increased blood pressure (hypertension) and heart rate, liver damage, increased pressure in the eye (glaucoma), and severe skin reactions

Increased Insulin Secretion When blood sugar levels rise, tirzepatide stimulates the pancreas to release insulin , allowing glucose to enter cells and reducing blood sugar levels